Jasper Therapeutics, Inc. (JSPR) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
Glancy Prongay & Murray LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Jasper Therapeutics, Inc. (“Jasper” or the “Company”) (NASDAQ: JSPR). https://mma.prnewswire.com/media/1219482/Glancy_Prongay_and_Murray_LLP.jpg IF YOU SUFFERED A LOSS ON YOUR JASPER INVESTMENTS, CLICKHERE BEFORE NOVEMBER 18, 2025 (LEAD PLAINTIFF DEADLINE) TO PARTICIPATE IN THE SECURITIES FRAUD LAWSUIT […]